Status:
UNKNOWN
Prevalence and Predictors of Osteoporosis in the Beijing's Urban Population
Lead Sponsor:
China-Japan Friendship Hospital
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Osteoporosis
Eligibility:
All Genders
20-79 years
Brief Summary
1. To establish a BMD reference database of Beijing's urban population, China. 2. To determine the prevalences and risk factors of osteoporosis and osteopenia in Beijing's urban population, China. 3. ...
Detailed Description
With one of the biggest populations in the world, China was heavily suffered from osteoporosis. The prevalence of osteoporosis in China even is increasing fast in recent years, which are especially no...
Eligibility Criteria
Inclusion
- 20 to 79 residents in urban Beijing, China.
Exclusion
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT01476150
Start Date
January 1 2012
End Date
March 1 2014
Last Update
November 23 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029